MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE, IN VARIOUS FILL SIZES - 1 ML FILL IN 3 ML SYRINGE LL; 1 ML FILL IN 6 ML SYRINGE LL
K993518 · Medefil, Inc. · FOZ · Jun 12, 2000 · General Hospital
Device Facts
Record ID
K993518
Device Name
MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE, IN VARIOUS FILL SIZES - 1 ML FILL IN 3 ML SYRINGE LL; 1 ML FILL IN 6 ML SYRINGE LL
Applicant
Medefil, Inc.
Product Code
FOZ · General Hospital
Decision Date
Jun 12, 2000
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.5200
Device Class
Class 2
Attributes
Therapeutic
Intended Use
FOR USE TO MAINTAIN PATENCY OF IN-DWELLING INTRAVENOUS ACCESS DEVICES (IVAD)
Device Story
Medefil's Heparin I.V. Flush Syringe is a sterile, pre-filled syringe containing heparin solution. It is used by healthcare professionals in clinical settings to flush in-dwelling intravenous access devices (IVADs). The primary function is to maintain the patency of the IV line by preventing clot formation within the catheter. The device is a single-use, disposable syringe, which simplifies the flushing process, reduces the risk of medication errors associated with manual preparation, and minimizes potential contamination during the flushing procedure. It serves as a direct replacement for manually prepared heparin flush syringes.
Clinical Evidence
bench testing only
Technological Characteristics
Sterile, pre-filled syringe containing heparin solution. Single-use, disposable form factor. Class II device (Product Code: FOZ).
Indications for Use
Indicated for maintaining patency of in-dwelling intravenous access devices (IVAD) in patients requiring intravenous therapy.
Regulatory Classification
Identification
An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.
K133446 — HEPARIN LOCK / FLUSH SYRINGES · Excelsior Medical Corporation · Nov 14, 2014
K990308 — ROCAP HEPARIN IV FLUSH SYRINGE, 100U/ML · Rocap Div. of Sabratek Corp. · Dec 10, 1999
K092491 — MEDEFIL'S HEPARIN I.V. FLUSH SYRINGE 1 UNIT/ML; 10 UNITS/ML; AND 100 UNITS/ML IN VARIOUS FILL SIZES · Medefil, Inc. · Feb 3, 2010
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image contains the words "Public Health Service" in bold, black font. The text is horizontally aligned and appears to be a title or heading. The background is plain white, providing a clear contrast for the text.
Image /page/0/Picture/2 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of an eagle with its wings spread.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 1 2 2000
Mr. Pradeep Aggarwal President-CEO Medefil's, Incorporated 492 Lunt Avenue Schaumburg, Illinois 60193
K993518 Re : Medefil's Heparin I.V. Flush Syringe, In Trade Name: Various Fill Size Regulatory Class: II Product Code: FOZ March 20, 2000 Dated: Received: March 21, 2000
#### Dear Mr. Aggarwal:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) requlation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in Please note: this response to your the Federal Register. premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
#### Page 2 - Mr. Aggarwal
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labelinq regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other gener Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Timothy A. Ulatowski
Timothy A. Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
K993518
Medefil, Inc. October, 1999 Sterile Heparin I. V. Flush Syringe Indications For Use
:
Page _________________________________________________________________________________________________________________________________________________________________________
510(k) Number (if known): ____Pending
Heparin I. V. Flush Syringe Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications For Use:
# FOR USE TO MAINTAIN PATENCY OF IN-DWELLING INTRAVENOUS ACCESS DEVICES (IVAD)
# (PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
# Concurrence of CDRH, Office of Device Evaluation (ODE)
Patricio Cucenita
(Division Sign-Off)
Division of Dental, Infection Control, and General Hospital Devices
510(k) Number K993578
(Optional Format 3-10-98)
#### 000020
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.